Zekhariah Inyasio Idro, PA-C

Zekhariah Idro practices at Apple Urgent Care - Indio in Indio, California.

Zekhariah Idro's NPI, 1922416023, was assigned on August 1, 2014. Zekhariah Idro holds California license 52215.

Zekhariah Idro's primary practice is Apple Urgent Care - Indio, at 82013 Doctor Carreon Blvd, Indio, CA 92201 in Riverside County. The practice phone is (760) 775-9500.

Zekhariah Idro's primary practice is Apple Urgent Care - Indio in Indio, California. The medical group on file is Apple Urgent Care. Dmand AI also links Zekhariah Idro to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Zekhariah Idro practices. Vendor and product names are available with a free account.

Physician assistant is Zekhariah Idro's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Zekhariah Idro is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Dmand AI has Zekhariah Idro's licenses on file in 2 states: California and Nebraska.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, ear infection, itchy rashes, lower back pain and psoriasis among the conditions Zekhariah Idro treats.

CMS data shows 858 Medicare services from Zekhariah Idro across 9 procedure codes in 2024, for 197 Medicare patients. Medicare paid $45,294 for them. Every service was in an office.

CMS counts 197 Medicare patients who saw Zekhariah Idro in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 56% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Zekhariah Idro's median patient age at 35, with 59% women.

In 2024, Zekhariah Idro wrote 2,012 Medicare Part D claims for 458 patients. 91% of them were for generic drugs. CMS names the drug for 1,825 of them, across 30 drugs with 11 or more claims each, at $221,107 in total drug cost.

Zekhariah Idro accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 73 general payments to Zekhariah Idro from 9 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 90% of the total. Sanofi and Genzyme US Companies paid the most, $479.